Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

IMMU-106

Known as: monoclonal antibody IMMU-106 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
8032 Background: An open-label, multicenter study has shown that the humanized anti-CD20 antibody, IMMU-106 (hA20), which has… Expand
Is this relevant?
Review
2012
Review
2012
Antibody-based therapeutic approaches have had a significant impact in the treatment of non-Hodgkin’s lymphoma (NHL). Rituximab’s… Expand
  • table I
  • figure 1
  • table II
Is this relevant?
Review
2012
Review
2012
Over the last few years, new generations of anti-CD20 monoclonal antibodies (mAbs) have been developed for potential benefits… Expand
  • table I
  • table II
Is this relevant?
Review
2009
Review
2009
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by B cell hyperactivity and defective T-cell function… Expand
Is this relevant?
2007
2007
Purpose:Bispecific antibody (bsMAb) pretargeting procedures use divalent hapten-peptides to stabilize the binding of the hapten… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2006
2006
7530 Background: The humanized anti-CD20 antibody, IMMU-106 (hA20), has similar murine CDRs to rituximab, but the remaining… Expand
Is this relevant?
2006
2006
Background: An open-label, multicenter, dose-escalation study in patients with recurrent NHL was initially undertaken to… Expand
Is this relevant?
2006
2006
2536 Background: Anti-CD20 and anti-CD22 monoclonal antibodies (MAbs) have been shown to have antitumor activity in non-Hodgkin's… Expand
Is this relevant?
2005
2005
Background. Infusion reactions, prolonged infusion times and immunogenicity of the chimeric anti-CD20 antibody, rituximab, may in… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE A new humanized anti-CD20 monoclonal antibody (MAb), IMMU-106, was evaluated to elucidate its action as an antilymphoma… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 4
Is this relevant?